Sandy Z.

Sandy Z. has extensive work experience in the biotechnology and pharmaceutical industry. Currently, they serve as the Chairman of the Board at Carisma Therapeutics since November 2021. Sandy is also the Acting President & Chair of the Business Advisory Board at IMIDomics Inc. since June 2022. Prior to this, they held the position of Executive Chair at Kaerus Bioscience Ltd. starting from February 2021.

Sandy Z. has held various leadership roles in different companies. Sandy served as a Director at ESSA Pharmaceuticals and a Board Member at The Smart Program, both starting from July 2019. Sandy was also a Non-Executive Director at Compugen Ltd. from June 2018.

From December 2019 to July 2022, Sandy Z. held the position of Executive Chairman/Leadership Team at Janpix, Inc - a Centessa Company. Additionally, they were the former Chair and current Consultant at Palladio Biosciences, Inc., another Centessa Company, from April 2019 to July 2022.

Before that, Sandy Z. worked as a Venture Partner at Medicxi from February 2020 to June 2021. Sandy also served as the Chairman at IMIDomics, Inc. from March 2015 to June 2021.

Overall, Sandy Z. has held various leadership and advisory positions in biotech and pharmaceutical companies, showcasing their expertise and knowledge in the industry.

Sandy Z.'s education history is as follows. Sandy first attended UC San Diego where they pursued a Bachelor of Arts (BA) degree in Biology. The start and end years for this education are not specified. After completing their undergraduate degree, they went on to attend the University of California, Davis from 1980 to 1984. Here, they obtained a Master of Science (MS) degree in Human Physiology. Finally, Sandy Z. also took accounting and business courses at Pace University, although the start and end years for this are not provided, and they did not earn a specific degree in this field.